Applied DNA, ITW Pillar enter traceability agreement for PPE
Posted September 23, 2020
STONY BROOK, N.Y. – Applied DNA Sciences, Inc., a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing that enables in vitro diagnostics, pre-clinical nucleic acid-based therapeutic drug candidates, supply chain security, anti-counterfeiting and anti-theft technology, announced that it has entered into a supply agreement for its CertainT® platform with ITW Pillar Technologies, a division of Illinois Tool Works (ITW).
Under the terms of the Agreement, Applied DNA will supply SigNature® molecular tags and SigNify® in-field authentication devices to Pillar for use on materials and products treated with Pillar’s patented plasma deposition technology. Said materials and products will carry Applied DNA’s CertainT trademark, representing authenticity, origin, traceability, sustainability and quality that will bring transparency to Pillar’s customers’ supply chains and enable these customers to promote traceability and trust in the materials used in their products.
Pillar’s systems are utilized by many of the leading manufacturers of N95 masks, gowns and other equipment used by frontline healthcare practitioners. Plasma deposition technology allows for the finishing of textiles that imparts varying enhanced characteristics – wickability, breathability, ink and dye uptake, antimicrobial, hydrophobicity, etc. – that are ecofriendly to apply relative to traditional wet-chemical processes. The agreement supports Pillar’s strategy to combat the growing issue of counterfeit PPE entering the healthcare supply chain as the COVID-19 pandemic increases demand and has grown to include other materials and products manufactured by Pillar’s customers.
Pillar personnel will be fully trained in the application of the unique molecular tags and in the use of the in-field authentication systems. Pillar will incorporate SigNature molecular tags into textiles including, but not limited to, polypropylene, cotton, recycled polyester, nylon, wool and viscose for the manufacture of products, including those used in the manufacture of Personal Protective Equipment (PPE). Authentication of all tagged materials and products will be tracked via CertainT’s cloud-based portal for ease of access by Pillar and its customers.
“We believe our partnership with Applied DNA in the deployment of its CertainT platform across our manufacturing lines provides brands and manufacturers the most advanced and secure plasma-based systems available on the market globally,” said Rory Wolf, CEO of ITW Pillar Technologies. “As the standard of proof and need for greater transparency continues to increase, so too does the need to have a scientific basis to support sustainability goals and ongoing commercial programs. Our customers now have the complete solution that gives them formidable brand protection and assurance with forensic certainty. We are especially pleased to offer definitive proof of the authenticity of PPE materials to customers at a time when COVID-19-fueled demand has led to an influx of substandard and falsified product in the healthcare supply chain.”
Commenting on the agreement, MeiLin Wan, vice president of Textiles at Applied DNA, said: “Pillar represents further adoption of our CertainT platform and another avenue for the commercialization of our supply chain security solutions. Having validated and proven that our CertainT platform can work on a wide range of substrates with Pillar, the advancement in portable testing together with advancements in non-chemical applications for textiles and other materials provides a compelling solution for branded and proprietary products that require a trusted, market-ready solution.”
Source: Applied DNA